First Time Loading...

Rhinomed Ltd
ASX:RNO

Watchlist Manager
Rhinomed Ltd Logo
Rhinomed Ltd
ASX:RNO
Watchlist
Price: 0.04 AUD Market Closed
Updated: Apr 30, 2024

Rhinomed Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rhinomed Ltd
Cash from Financing Activities Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
C
CU6

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Rhinomed Ltd
ASX:RNO
Cash from Financing Activities
AU$5.5m
CAGR 3-Years
-23%
CAGR 5-Years
10%
CAGR 10-Years
10%
Mayne Pharma Group Ltd
ASX:MYX
Cash from Financing Activities
-AU$431.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Cash from Financing Activities
AU$3.6m
CAGR 3-Years
-43%
CAGR 5-Years
-21%
CAGR 10-Years
-18%
Botanix Pharmaceuticals Ltd
ASX:BOT
Cash from Financing Activities
AU$36.2m
CAGR 3-Years
N/A
CAGR 5-Years
11%
CAGR 10-Years
46%
Probiotec Ltd
ASX:PBP
Cash from Financing Activities
-AU$11.1m
CAGR 3-Years
N/A
CAGR 5-Years
-1%
CAGR 10-Years
0%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Cash from Financing Activities
AU$231.6k
CAGR 3-Years
-70%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Rhinomed Ltd's Cash from Financing Activities?
Cash from Financing Activities
5.5m AUD

Based on the financial report for Jun 30, 2023, Rhinomed Ltd's Cash from Financing Activities amounts to 5.5m AUD.

What is Rhinomed Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
10%

Over the last year, the Cash from Financing Activities growth was -13%. The average annual Cash from Financing Activities growth rates for Rhinomed Ltd have been -23% over the past three years , 10% over the past five years , and 10% over the past ten years .